These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 18156316

  • 1. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
    Seo SK, Jin HO, Lee HC, Woo SH, Kim ES, Yoo DH, Lee SJ, An S, Rhee CH, Hong SI, Choe TB, Park IC.
    Mol Pharmacol; 2008 Mar; 73(3):1005-12. PubMed ID: 18156316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    Denlinger CE, Rundall BK, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Nov; 128(5):740-8. PubMed ID: 15514602
    [Abstract] [Full Text] [Related]

  • 4. The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells.
    Portanova P, Russo T, Pellerito O, Calvaruso G, Giuliano M, Vento R, Tesoriere G.
    Int J Oncol; 2008 Aug; 33(2):325-31. PubMed ID: 18636153
    [Abstract] [Full Text] [Related]

  • 5. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
    Emanuele S, Lauricella M, Carlisi D, Vassallo B, D'Anneo A, Di Fazio P, Vento R, Tesoriere G.
    Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
    Rikiishi H, Shinohara F, Sato T, Sato Y, Suzuki M, Echigo S.
    Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
    [Abstract] [Full Text] [Related]

  • 7. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 8. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U, von Metzler I, Kaiser M, Rosche M, Sterz J, Rötzer S, Rademacher J, Jakob C, Fleissner C, Kuckelkorn U, Kloetzel PM, Sezer O.
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [Abstract] [Full Text] [Related]

  • 9. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH.
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
    Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O.
    J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
    [Abstract] [Full Text] [Related]

  • 13. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
    Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB.
    Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
    [Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
    Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM.
    Cancer Res; 2004 Dec 01; 64(23):8778-81. PubMed ID: 15574791
    [Abstract] [Full Text] [Related]

  • 15. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.
    Facchetti F, Previdi S, Ballarini M, Minucci S, Perego P, La Porta CA.
    Apoptosis; 2004 Sep 01; 9(5):573-82. PubMed ID: 15314285
    [Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 17. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):223-9. PubMed ID: 15850925
    [Abstract] [Full Text] [Related]

  • 18. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P.
    Cancer Chemother Pharmacol; 2010 Nov 01; 66(6):1131-40. PubMed ID: 20838997
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J, Kumar KS, Heesch S, Müller C, Hartwig C, Maass M, Bader P, Beck JF.
    Int J Oncol; 2006 Mar 01; 28(3):755-66. PubMed ID: 16465382
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
    Yu C, Friday BB, Lai JP, McCollum A, Atadja P, Roberts LR, Adjei AA.
    Clin Cancer Res; 2007 Feb 15; 13(4):1140-8. PubMed ID: 17317822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.